Home » Topics » Conferences

Conferences
RSS

NCI discloses anti-HIV agent with novel mechanism of action

Jan. 31, 1997

Abbott develops protease inhibitor for combination therapy

Jan. 31, 1997

Thalidomide: Forty years later

Jan. 30, 1997

Cidofovir highlighted at retroviral conference

Jan. 30, 1997

Pilot trial of folic acid in stroke patients

Jan. 30, 1997

Famvir safe and effective in HIV-infected patients with shingles

Jan. 30, 1997

Encouraging results reported for Merck anti-HIV combination

Jan. 30, 1997

Triple combination therapy dramatically effective in HIV/AIDS

Jan. 30, 1997

Doxil superior to other treatments for first-line treatment of Kaposi's sarcoma

Jan. 29, 1997

Combination HIV-IG/MAbs shows synergistic anti-HIV effects

Jan. 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...